73579000: Carbidopa (substance)

SNOMED CT Concept\substance\...

\Drug or medicament (substance)\Central nervous system agent (substance)\Antiparkinsonian agent (substance)\...

\inhibiteur de la dopa-décarboxylase\Carbidopa

\Dihydroxyphenylalanine\Carbidopa

\substance catégorisée selon sa structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Catecholamine and/or catecholamine derivative\Catecholamine\Dihydroxyphenylalanine\Carbidopa

\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Catecholamine and/or catecholamine derivative\Catecholamine\Dihydroxyphenylalanine\Carbidopa

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Carbidopa	est un(e) (attribut)	Antiparkinsonian agent (substance)	false	Inferred relationship	Some
Carbidopa	est un(e) (attribut)	Co-careldopa (substance)	false	Inferred relationship	Some
Carbidopa	est un(e) (attribut)	Co-careldopa (product)	false	Inferred relationship	Some
Carbidopa	est un(e) (attribut)	Dihydroxyphenylalanine	true	Inferred relationship	Some
Carbidopa	est un(e) (attribut)	inhibiteur de la dopa-décarboxylase	true	Inferred relationship	Some
Carbidopa	Has disposition (attribute)	Dopamine receptor agonist (disposition)	true	Inferred relationship	Some
Carbidopa	Has disposition (attribute)	Dihydroxyphenylalanine decarboxylase inhibitor (disposition)	true	Inferred relationship	Some
Carbidopa	est un(e) (attribut)	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing only carbidopa (medicinal product)	a pour principe actif (attribut)	True	Carbidopa	Inferred relationship	Some	1
Product containing only carbidopa and entacapone and levodopa (medicinal product)	a pour principe actif (attribut)	True	Carbidopa	Inferred relationship	Some	3
Product containing only carbidopa and levodopa (medicinal product)	a pour principe actif (attribut)	True	Carbidopa	Inferred relationship	Some	2
Product containing only carbidopa and levodopa in oral dose form (medicinal product form)	a pour principe actif (attribut)	True	Carbidopa	Inferred relationship	Some	2
Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form)	a pour principe actif (attribut)	True	Carbidopa	Inferred relationship	Some	3
Carbidopa and levodopa only product in enteral dose form	a pour principe actif (attribut)	True	Carbidopa	Inferred relationship	Some	2
Carbidopa only product in oral dose form	a pour principe actif (attribut)	True	Carbidopa	Inferred relationship	Some	1
Carbidopa (as carbidopa monohydrate) 25 mg and levodopa 100 mg oral tablet	Has basis of strength substance (attribute)	False	Carbidopa	Inferred relationship	Some	2
Carbidopa (as carbidopa monohydrate) 25 mg and levodopa 250 mg oral tablet	Has basis of strength substance (attribute)	False	Carbidopa	Inferred relationship	Some	2
Carbidopa anhydrous	Is modification of (attribute)	True	Carbidopa	Inferred relationship	Some
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has precise active ingredient	True	Carbidopa	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	Has precise active ingredient	True	Carbidopa	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet	Has precise active ingredient	True	Carbidopa	Inferred relationship	Some	3
Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form)	a pour principe actif (attribut)	True	Carbidopa	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has precise active ingredient	True	Carbidopa	Inferred relationship	Some	3
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has precise active ingredient	True	Carbidopa	Inferred relationship	Some	2
Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Carbidopa	Inferred relationship	Some	2
Carbidopa- and levodopa-containing product in oromucosal dose form	a pour principe actif (attribut)	True	Carbidopa	Inferred relationship	Some	2
Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Carbidopa	Inferred relationship	Some	2
Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet	Has precise active ingredient	True	Carbidopa	Inferred relationship	Some	2
Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet	Has basis of strength substance (attribute)	True	Carbidopa	Inferred relationship	Some	2
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Has precise active ingredient	True	Carbidopa	Inferred relationship	Some	2
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Carbidopa	Inferred relationship	Some	2
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Carbidopa	Inferred relationship	Some	1
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Carbidopa	Inferred relationship	Some	2
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Carbidopa	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg oral tablet	Has precise active ingredient	True	Carbidopa	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 12.5 mg and levodopa 50 mg oral tablet	Has precise active ingredient	True	Carbidopa	Inferred relationship	Some	2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Carbidopa	Inferred relationship	Some	3
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Carbidopa	Inferred relationship	Some	3
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Carbidopa	Inferred relationship	Some	3
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Carbidopa	Inferred relationship	Some	3
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Carbidopa	Inferred relationship	Some	3
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Carbidopa	Inferred relationship	Some	3
Carbidopa measurement	élément (attribut)	True	Carbidopa	Inferred relationship	Some	1
Levodopa with carbidopa (product)	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some
Carbidopa 12.5 mg and levodopa 50 mg oral tablet	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some
Co-careldopa 10mg/100mg tablet (product)	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some
Co-careldopa 25mg/100mg tablet (product)	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some
Co-careldopa 25mg/250mg tablet (product)	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some
Co-careldopa 50mg/200mg m/r tablet (product)	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some
Co-careldopa 25mg/100mg m/r tablet (product)	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some
Co-careldopa (product)	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some
Carbidopa 25 mg oral tablet	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some
Carbidopa + levodopa 50mg/200mg m/r tablet (product)	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some
Carbidopa 10 mg and levodopa 100 mg oral tablet	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some
Carbidopa 25 mg and levodopa 100 mg oral tablet	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some
Carbidopa 25 mg and levodopa 250 mg oral tablet	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some
Carbidopa + levodopa 25mg/100mg m/r tablet (product)	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some
Product containing carbidopa (medicinal product)	a pour principe actif (attribut)	True	Carbidopa	Inferred relationship	Some	1
Product containing carbidopa and levodopa (medicinal product)	a pour principe actif (attribut)	True	Carbidopa	Inferred relationship	Some	2
médicament contenant lévodopa et carbidopa et entacapone	a pour principe actif (attribut)	True	Carbidopa	Inferred relationship	Some	3
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug)	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some
Co-careldopa (substance)	est un(e) (attribut)	False	Carbidopa	Inferred relationship	Some
Carbidopa 10mg/levodopa 100mg orally disintegrating tablet (product)	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some
Carbidopa 25mg/levodopa 100mg orally disintegrating tablet (product)	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some
Carbidopa 25mg/levodopa 250mg orally disintegrating tablet (product)	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some
Carbidopa + levodopa adverse reaction	Causative agent	False	Carbidopa	Inferred relationship	Some	2
Allergy to carbidopa and levodopa	Causative agent	False	Carbidopa	Inferred relationship	Some
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug)	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some
Carbidopa 18.75mg + levodopa 75mg + entacapone 200mg tablet	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some
Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some
Product containing carbidopa and levodopa in oral dose form (medicinal product form)	a pour principe actif (attribut)	True	Carbidopa	Inferred relationship	Some	2
Carbidopa measurement	Has measured component	False	Carbidopa	Inferred relationship	Some
Carbidopa monohydrate (substance)	est un(e) (attribut)	False	Carbidopa	Inferred relationship	Some
Carbidopa 12.5 mg and levodopa 50 mg oral tablet	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some	2
Carbidopa 12.5 mg and levodopa 50 mg oral tablet	Has basis of strength substance (attribute)	False	Carbidopa	Inferred relationship	Some	2
Carbidopa 25 mg oral tablet	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some	1
Carbidopa 25 mg oral tablet	Has basis of strength substance (attribute)	False	Carbidopa	Inferred relationship	Some	1
Carbidopa 10 mg and levodopa 100 mg oral tablet	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some	1
Carbidopa 10 mg and levodopa 100 mg oral tablet	Has basis of strength substance (attribute)	False	Carbidopa	Inferred relationship	Some	1
Carbidopa 25 mg and levodopa 100 mg oral tablet	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some	2
Carbidopa 25 mg and levodopa 100 mg oral tablet	Has basis of strength substance (attribute)	False	Carbidopa	Inferred relationship	Some	2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some	1
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Carbidopa	Inferred relationship	Some	1
Carbidopa 10 mg and levodopa 100 mg oral tablet	Has basis of strength substance (attribute)	False	Carbidopa	Inferred relationship	Some	2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug)	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some	1
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Carbidopa	Inferred relationship	Some	1
Carbidopa 25 mg and levodopa 100 mg oral tablet	Has basis of strength substance (attribute)	False	Carbidopa	Inferred relationship	Some	1
Carbidopa 25 mg and levodopa 250 mg oral tablet	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some	1
Carbidopa 25 mg and levodopa 250 mg oral tablet	Has basis of strength substance (attribute)	False	Carbidopa	Inferred relationship	Some	1
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Carbidopa	Inferred relationship	Some	2
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug)	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some	2
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Carbidopa	Inferred relationship	Some	2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet	Has basis of strength substance (attribute)	True	Carbidopa	Inferred relationship	Some	3
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet	a pour principe actif (attribut)	False	Carbidopa	Inferred relationship	Some	2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet	Has basis of strength substance (attribute)	False	Carbidopa	Inferred relationship	Some	2
Carbidopa 12.5 mg and levodopa 50 mg oral tablet	Has basis of strength substance (attribute)	False	Carbidopa	Inferred relationship	Some	1
Product containing carbidopa and levodopa in enteral dose form (medicinal product form)	a pour principe actif (attribut)	True	Carbidopa	Inferred relationship	Some	2
Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Carbidopa	Inferred relationship	Some	1
Carbidopa (as carbidopa monohydrate) 25 mg and levodopa 100 mg prolonged-release oral tablet	Has basis of strength substance (attribute)	False	Carbidopa	Inferred relationship	Some	1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet	Has precise active ingredient	True	Carbidopa	Inferred relationship	Some	3
Carbidopa 25 mg oral tablet	Has precise active ingredient	False	Carbidopa	Inferred relationship	Some	1
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	False	Carbidopa	Inferred relationship	Some	2
Carbidopa 25 mg and levodopa 100 mg oral tablet	Has precise active ingredient	False	Carbidopa	Inferred relationship	Some	1
Product containing carbidopa in oral dose form (medicinal product form)	a pour principe actif (attribut)	True	Carbidopa	Inferred relationship	Some	1
Carbidopa 25 mg and levodopa 250 mg oral tablet	Has precise active ingredient	False	Carbidopa	Inferred relationship	Some	1
Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form)	a pour principe actif (attribut)	True	Carbidopa	Inferred relationship	Some	3
Carbidopa 12.5 mg and levodopa 50 mg oral tablet	Has precise active ingredient	False	Carbidopa	Inferred relationship	Some	1

Page 1 of 2 End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
122178011	Carbidopa	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
122179015	MK-486	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
122180017	alpha-Methyldopa hydrazine	en	Synonym (core metadata concept)	Inactive	Entire term case sensitive (core metadata concept)	SNOMED CT core
3736797013	Alpha-methyldopa hydrazine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
462701000241110	carbidopa (substance)	fr	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
797681000172110	carbidopa	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
7981000188117	Carbidopa	fr	Synonym (core metadata concept)	Inactive	Entire term case sensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
813982014	Carbidopa (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core